Contravir hepion
Web--ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non … WebMar 20, 2024 · Developer ContraVir Pharmaceuticals; Hepion Pharmaceuticals; HepQuant Class Antineoplastics; Cardiovascular therapies Mechanism of Action Cyclophilin inhibitors; Sodium-bile acid cotransporter modulators Orphan Drug Status Yes - Liver cancer New Molecular Entity Yes Available For Licensing Yes Highest Development Phases
Contravir hepion
Did you know?
WebJul 22, 2024 · ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to HEPA. Posted on 07/22/2024 287 WebSenior Director, Clinical Development at Hepion Pharmaceuticals, Inc. Penns Park, Pennsylvania, United States 366 followers 358 connections …
WebHepion Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of targeted antiviral therapies with two candidates in mid-to-late … WebMay 1, 2024 · ContraVir's current market capitalization is $20,388,290 (at a share price of $0.24 as of the market close on 04/26/18 and 84,951,212 outstanding shares as per the latest 10-KT filed on March 26 ...
WebHepion Pharmaceuticals net income from 2014 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for. Compare HEPA With Other Stocks From: To: Zoom: -0.05 -0.04 -0.03 -0.02 -0.01 Trailing 12 Months -0.03 -0.02 -0.01 0.00 Quarterly WebJul 24, 2024 · The third part of the study will assess the safety, tolerability, PK, and preliminary signal for antiviral efficacy and identification of clinically-relevant biomarkers …
WebFind the latest ContraVir Pharmaceuticals, Inc. (CTRVP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Hepion Pharmaceuticals Expands ...
WebPreviously Dr. Matkovits served as the Chief Operating Officer of ContraVir Pharmaceuticals (now Hepion) (NASDAQ: CTRV) where she was instrumental in the establishment and build-out of its global development organization with responsibility and oversight for Clinical Development, Regulatory, Manufacturing, Quality, and Project … ink of the skyWebJul 4, 2024 · Hepion Pharmaceuticals Inc., formerly ContraVir Pharmaceuticals, Inc., is a clinical stage biopharmaceutical company. The Company is focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection. Its lead oral drug candidate, CRV431, reduces liver ... mobility scooter atgWebHepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”), and other chronic diseases. mobility scooter anti tip wheelsmobility scooter at costcoWebPhone Number +1 732 902-4000. Hepion Pharmaceuticals provides the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and … inkognito browser appWebNov 21, 2024 · Shares of Hepion Pharmaceuticals Inc HEPA, formerly ContraVir Pharma, are ripping higher after the thinly-traded, nano-cap biotech announced results from an … mobility scooter at amazonWebHepion Pharmaceuticals Inc., formerly ContraVir Pharmaceuticals, Inc., is a clinical stage biopharmaceutical company. The Company is focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection. Its lead oral drug candidate, CRV431, reduces liver ... mobility scooter aruba